M. Tambas Et Al. , "Conventionally-fractionated VMAT vs. SBRT in prostate cancer: PSA kinetics, toxicity, quality of life," RADIOTHERAPY AND ONCOLOGY , vol.119, 2016
Tambas, M. Et Al. 2016. Conventionally-fractionated VMAT vs. SBRT in prostate cancer: PSA kinetics, toxicity, quality of life. RADIOTHERAPY AND ONCOLOGY , vol.119 .
Tambas, M., Agaoglu, F., Iribas, A., Guveli, M., Dizdar, Y., Okutan, M., ... Ozkan, D.(2016). Conventionally-fractionated VMAT vs. SBRT in prostate cancer: PSA kinetics, toxicity, quality of life. RADIOTHERAPY AND ONCOLOGY , vol.119.
Tambas, M. Et Al. "Conventionally-fractionated VMAT vs. SBRT in prostate cancer: PSA kinetics, toxicity, quality of life," RADIOTHERAPY AND ONCOLOGY , vol.119, 2016
Tambas, M. Et Al. "Conventionally-fractionated VMAT vs. SBRT in prostate cancer: PSA kinetics, toxicity, quality of life." RADIOTHERAPY AND ONCOLOGY , vol.119, 2016
Tambas, M. Et Al. (2016) . "Conventionally-fractionated VMAT vs. SBRT in prostate cancer: PSA kinetics, toxicity, quality of life." RADIOTHERAPY AND ONCOLOGY , vol.119.
@article{article, author={M. Tambas Et Al. }, title={Conventionally-fractionated VMAT vs. SBRT in prostate cancer: PSA kinetics, toxicity, quality of life}, journal={RADIOTHERAPY AND ONCOLOGY}, year=2016}